Search Press releases

Press releases teaser image
27 Jun 2025

UCB announces positive results from GEMZ phase 3 study of fenfluramine in CDKL5 Deficiency Disorder

Read More
Press releases teaser image
20 Jun 2025

UCB to present new data from its neurology portfolio at the 11th European Academy of Neurology (EAN) Congress 2025

Read More
Press releases teaser image
16 Jun 2025

Transparency notification FMR LLC

Read More
Press releases teaser image
12 Jun 2025

UCB Announces Major U.S. Investment to Expand Biologics Manufacturing Capacity

Read More
Press releases teaser image
12 Jun 2025

Dapirolizumab Pegol Phase 3 Data in SLE Presented at the Annual European Congress of Rheumatology (EULAR) Show Improvement in Fatigue and Reduction in Disease Activity

Read More
Press releases teaser image
11 Jun 2025

BIMZELX[®]▼(bimekizumab) three-year data at EULAR 2025 showed lasting efficacy and control of inflammation in psoriatic arthritis and axial spondyloarthritis

Read More

Stay up-to-date on the latest news and information from UCB

Subscribe